asunaprevir
Jump to navigation
Jump to search
Indications
- treatment of refractory hepatitis C, including those with HCV genotype 1 infection[1]
Dosage
- 600 mg BID
Mechanism of action
More general terms
References
- ↑ 1.0 1.1 Lok AS et al. Preliminary study of two antiviral agents for hepatitis C genotype 1. N Engl J Med 2012 Jan 19; 366:216. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22256805
Chung RT. A watershed moment in the treatment of hepatitis C. N Engl J Med 2012 Jan 19; 366:273. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22256811